Benefits & Executive Compensation News
View and Filter All Stories

Latest Stories

AbbVie, Teva, Others Score Early Win in Bystolic Antitrust Case

AbbVie Inc. and a group of generic drug manufacturers notched an initial victory Monday against antitrust litigation over their alleged scheme to delay generic versions of the blood pressure medication Bystolic, when a federal judge in Manhattan tentatively tossed the consolidated case.

Burst of 401(k) Fee Litigation Gets Boost From Supreme Court (2)

The U.S. Supreme Court revived a lawsuit against Northwestern University Monday in a decision that may breathe new life into dozens of lawsuits across the country that take aim at retirement plans with poorly performing investments and excessive recordkeeping fees.

View More